Cevimeline Hydrochloride Capsule
Product Images NDC 72789-457

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cevimeline Hydrochloride (NDC 72789-457). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789457 Label (72789457)

Label for Cevimeline Hydrochloride 30 mg capsules, containing 30 capsules per package. The product is a prescription oral capsule marketed and packaged by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK, and manufactured by Rubicon Research Private Limited, India. Storage instructions specify controlled room temperature. Includes NDC 72789-457-30 and barcode.*

FDA Label Image

The Structural Formula For Cevimeline Is Cis -2’-methylspiro{1-azabicyclo [2.2.2] Octane-3, 5’-[1,3] Oxathiolane} Hydrochloride, Hydrate (2:1). Its Empirical Formula Is C10h17nos.hcl. (Cevimeline Hydrochloride Capsules Structure)

Chemical structure of cevimeline hydrochloride monohydrate, showing the molecular framework with sulfur, nitrogen, oxygen atoms, and associated hydrochloride and water of hydration components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.